Prof. ALİ İBRAHİM HATEMİ

Publication Network

Articles 92

1. Ustekinumab may have therapeutic effects on autoimmune thyroid disease

Guzel S. S., DEMİR A., EŞKAZAN T., HATEMİ A. İ., GÖNEN M. S.

Scientific Reports , vol.16, no.1, 2026 (SCI-Expanded, Scopus)

2. Long-Term Oral Budesonide Use in Inflammatory Bowel Disease: Effects on Bone Mineral Density and Late-Onset Adverse Events

Eskazan T., BAKKALOĞLU O. K., DURCAN E., Akpinar A., Kurt E. A., Onal U., et al.

DIAGNOSTICS , vol.15, no.17, 2025 (SCI-Expanded, Scopus) Sustainable Development

3. Relationship with FIB-4, APRI scores and the clinical diagnosis in chronic liver diseases

PEKER P., HATEMI A. I.

Ege Tıp Dergisi , vol.64, no.2, pp.274-282, 2025 (TRDizin)

4. Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities

Marasco G., Hod K., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.

United European Gastroenterology Journal , vol.13, no.5, pp.798-818, 2025 (SCI-Expanded, Scopus)

5. Efficacy and Safety of Infliximab in Patients with Autoimmune Hepatitis

Efe C., Lytvyak E., Eşkazan T., Liberal R., Androutsakos T., Gökçe D. T., et al.

Hepatology , vol.81, no.6, pp.1660-1670, 2025 (SCI-Expanded, Scopus)

6. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

RHEUMATOLOGY , vol.64, no.4, pp.2034-2040, 2025 (SCI-Expanded, Scopus) Sustainable Development

7. Exploring congenital sucrase-isomaltase deficiency in autism spectrum disorder patients with irritable bowel syndrome symptoms: A prospective SI gene sequencing study.

Zubarioglu T., Ulgen D., Akca-Yesil S., Akbulut S., Onay H., Uzunyayla-Inci G., et al.

Autism research : official journal of the International Society for Autism Research , vol.18, no.1, pp.44-55, 2025 (SCI-Expanded, SSCI, Scopus)

8. P1117 A 24-year, single-centre perianal fistulizing Crohn’s disease cohort: documentation of demographics and factors influencing clinical and radiological remission

Bayar M., Bakkaloğlu O. K., Şirolu S., Sarı E., Hamid R., Tutar O., et al.

JOURNAL OF CROHN'S AND COLITIS , vol.1, no.19, pp.1117, 2025 (SCI-Expanded, Scopus)

9. Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome

Hod K., Marasco G., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.

Neurogastroenterology and Motility , 2025 (SCI-Expanded, Scopus)

10. COVID-19 Seroprevalence in Cirrhotic Patients and Effect of COVID-19 Infection on Liver Cirrhosis by Clinical Form in the Postinfectious Period

Oenal U., Oezbey D., Bakkaloglu O. K., EŞKAZAN T., Kurt E. A., HATEMİ A. İ., et al.

ISTANBUL MEDICAL JOURNAL , no.4, pp.304-310, 2024 (ESCI, TRDizin)

11. Comparative Value of CRP and FCP for Endoscopic and Histologic Remissions in Ulcerative Colitis

Bakkaloglu O. K., Sen G., KEPİL N., EŞKAZAN T., Kurt E. A., Onal U., et al.

DIAGNOSTICS , vol.14, no.20, 2024 (SCI-Expanded, Scopus) Sustainable Development

12. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP.

Küçükyurt S., EŞKAZAN T., Ayer M., Klllçklran Avcl B., Hatemi I., EŞKAZAN A. E.

Pleura and peritoneum , vol.9, no.1, pp.39-43, 2024 (ESCI)

13. Prevalance and risk factors of thromboembolism in Inflammatory Bowel Disease

Kati O., Bakkaloglu O. K., Hatemi I., Celik A. F., SEYAHİ E., Erzin Y.

JOURNAL OF CROHNS & COLITIS , 2024 (SCI-Expanded, Scopus)

14. P856 Influential factors on the clinical and radiological closure of resistant perianal fistula treated with stoma

Candan S., Bakkaloglu O. K., Bayar M., Eskazan T., Hatemi I., Erzin Y., et al.

JOURNAL OF CROHN'S AND COLITIS , vol.1, no.18, pp.856, 2024 (SCI-Expanded, Scopus)

15. Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver

Ozaslan E., GÜNŞAR F., Ormeci A. C., HATEMİ A. İ., Efe C., AKYOL G., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.34, 2023 (SCI-Expanded, Scopus, TRDizin)

16. Increase in transaminase levels during COVID-19 infection and its association with poor prognosis

Bakkaloglu O. K., Onal U., Eskazan T., Kurt E. A., Candan S., Karaali R., et al.

SINGAPORE MEDICAL JOURNAL , vol.64, no.10, pp.640-644, 2023 (SCI-Expanded, Scopus) Sustainable Development

17. Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behcet Syndrome

ESATOĞLU S. N., GÜNER S., Guler S., HATEMİ G., KEPİL N., ERZİN Y. Z., et al.

ARTHRITIS & RHEUMATOLOGY , pp.3068-3070, 2023 (SCI-Expanded, Scopus)

18. Axial Spondyloarthritis in Patients with Gastrointestinal Involvement of Behcet Syndrome

ÖZTÜRK M., ESATOĞLU S. N., HATEMİ A. İ., ÇELİK A. F., KARGIN O. A., ÖZ A., et al.

ARTHRITIS & RHEUMATOLOGY , pp.3067-3068, 2023 (SCI-Expanded, Scopus)

19. Is There A Connection Between Primary Hypophysitis and Celiac Disease?

Kara Z., EŞKAZAN T., ŞAHİN S., Durcan E., Sulu C., Demir A. N., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.132, no.1, pp.33-38, 2023 (SCI-Expanded, Scopus) Sustainable Development

20. RE: Is There a More Practical Way for Screening Minimal Hepatic Encephalopathy?

Eyice D., Ok A. M., Sonsuz A., Şenocak M. Ş., Durak M. N., Özdemir S., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.6, pp.673, 2023 (SCI-Expanded, Scopus, TRDizin)

21. Recurrent colorectal carcinoma presenting with ileus dueto small bowel metastases: A case report

Ak T., Copur M., Candan S., Hatemi A. İ.

Medicina Clinica Practica , vol.6, no.1, pp.0-11, 2022 (Scopus)

22. Immunogenicity of infliximab among patients with Behcet's syndrome: a controlled study

Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.36, no.6, 2018 (SCI-Expanded, Scopus)

23. Prevalence of fecal incontinence and associated risk factors in elderly outpatients: a cross-sectional study

Demir N., Yuruyen M., Atay K., Yavuzer H., Hatemi I., Doventas A., et al.

Aging Clinical and Experimental Research , vol.29, no.6, pp.1165-1171, 2017 (SCI-Expanded, Scopus)

24. What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?

HATEMI I., Esatoğlu S. N.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.28, 2017 (SCI-Expanded, Scopus, TRDizin)

25. Immunogenicity of Infliximab Among Patients with Behcet's Syndrome: A Controlled Study

Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.

ARTHRITIS & RHEUMATOLOGY , vol.69, 2017 (SCI-Expanded, Scopus)

26. Behçet's syndrome: providing integrated care.

Esatoglu S. N., Kutlubay Z., Ucar D., Hatemi I., Uygunoglu U., Siva A., et al.

Journal of multidisciplinary healthcare , vol.10, pp.309-319, 2017 (Scopus)

27. Apoptosis and Disease Severity is Associated with Insulin Resistance in Nonalcoholic Fatty Liver Disease

Atay K., Canbakan B., Koroglu E., Hatemi I., Canbakan M., Kepil N., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.80, no.2, pp.271-277, 2017 (SCI-Expanded, Scopus)

28. What is the diagnostic accuracy of faecal calprotectin regarding endoscopic relapse in Crohn's disease patients following ileocecal resection? A tertiary single center experience

Yildirim S., Demir N., Bozcan S., Erzin Y., Hatemi I., Celik A. F.

JOURNAL OF CROHNS & COLITIS , vol.11, 2017 (SCI-Expanded, Scopus)

29. Did toxicity profile of azathioprine changed within the last 10 years: comparative 17 years data from a single tertiary IBD center

Bozcan S., Hatemi I., Yildirim S., Demir N., Erzin Y., Celik A. F.

JOURNAL OF CROHNS & COLITIS , vol.11, 2017 (SCI-Expanded, Scopus)

30. Evaluation of non-invasive diagnostic methods as indicators of fibrosis in patients with nonalcoholic fatty liver disease

Atay K., Canbakan B., Alan Ö., Koroglu E., Hatemi I., Kepil N., et al.

BIOMEDICAL RESEARCH-INDIA , no.2, pp.565-570, 2017 (SCI-Expanded) Sustainable Development

31. Systemic vasculitis and the gut

Hatemi A. İ., Hatemi G., Çelik A. F.

CURRENT OPINION IN RHEUMATOLOGY , vol.29, no.1, pp.33-38, 2017 (SCI-Expanded, Scopus)

32. Fatal gastrointestinal bleeding and perforated duodenal ulcer: a rare complication of deferasirox in a patient with liver cirrhosis

Atay K., Eskazan T., Salihoglu A., HATEMİ A. İ.

BIOMEDICAL RESEARCH-INDIA , vol.28, no.12, pp.5620-5622, 2017 (SCI-Expanded, Scopus)

33. Systemic vasculitis and the gut

Hatemi I., Hatemi G., Çelik A. B.

CURRENT OPINION IN RHEUMATOLOGY , vol.29, no.1, pp.33-38, 2017 (SCI-Expanded, Scopus)

34. Serum autoantibody positivity and its impact on the treatment response of the genotype 1 chronic hepatitis C.

Erdal G. S., Hatemi I., Atay K., Canbakan B., Ozdemir S., Tuncer M., et al.

BIOMEDICAL RESEARCH-INDIA , vol.28, no.2, pp.866-868, 2017 (SCI-Expanded, Scopus) Sustainable Development

35. Prevalence of osteoporosis, osteopenia and vitamin d deficiency in cirrhotic patients.

Atay K., Hatemi I., Durcan E., Eskazan T., Bozcan S., SAHUTOGLU T., et al.

BIOMEDICAL RESEARCH-INDIA , vol.28, no.6, pp.2631-2635, 2017 (SCI-Expanded, Scopus)

36. Mucosal gastric calcinosis in a hypocalcaemic patient.

Dincay D., Atay K., Hatemi I., Kepil N., Keskin F. E., Apaydin T., et al.

Przeglad gastroenterologiczny , vol.12, no.1, pp.70-71, 2017 (Scopus)

37. Gastric Ulcers Related to The Transarterial Radioembolization of Yittrium-90 in A Patient with Paraganglioma

Atay K., Akkoc F. N., Samanci C., Gulsen F., Kepil N., Hatemi I.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.80, no.1, pp.85-86, 2017 (SCI-Expanded, Scopus)

38. Fecal Calprotectin Level Is Useful in Identifying Active Disease in Behcet's Syndrome Patients with Gastrointestinal Involvement: A Controlled Study

Esatoglu S. N., Hatemi I., Ozguler Y., Hatemi G., Uzun H., Celik A. F., et al.

ARTHRITIS & RHEUMATOLOGY , vol.68, 2016 (SCI-Expanded, Scopus)

39. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease

KÖROĞLU E., CANBAKAN B., ATAY K., HATEMI I., TUNCER M., Dobrucalı A. M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.27, no.4, pp.361-366, 2016 (SCI-Expanded, Scopus, TRDizin)

40. Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B

Atay K., Hatemi I., Canbakan B., Koroglu E., Durcan E., Yurttas B., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.27, no.3, pp.279-283, 2016 (SCI-Expanded, Scopus, TRDizin)

41. Demographic characteristics of chronic pancreatitis patients in the era of endosonography: Experience of a single tertiary referral center in Turkey

ŞİŞMAN G., Koroglu E., Erzin Y. Z., Hatemi I., Tuncer M., ŞENTÜRK H.

Turkish Journal of Gastroenterology , vol.27, no.3, pp.284-289, 2016 (SCI-Expanded, Scopus, TRDizin)

42. Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet’s Syndrome

HATEMİ A. İ., ESATOĞLU S. N., HATEMİ G., ERZİN Y. Z., YAZICI H., ÇELİK A. F.

MEDICINE , vol.95, 2016 (SCI-Expanded, Scopus)

43. Evolution of a long-term follow-up cohort of Crohn's disease with complex perianal fistula: from antibiotic to combined AZA and anti-TNF based treatment ending up clinical and radiological healing with or without stoma

Erzin Y., Ercaliskan K., Hatemi I., Atay K., Bozcan S., Demir N., et al.

JOURNAL OF CROHNS & COLITIS , vol.10, 2016 (SCI-Expanded, Scopus)

44. Comparison of the familial and sporadic cases of inflammatory bowel diseases in long-term follow-up regarding step-up treatment, clinical, and biochemical parameters

Bozcan S., Hatemi I., Erzin Y., Ayan G., Satman A., Gundogdu T., et al.

JOURNAL OF CROHNS & COLITIS , vol.10, 2016 (SCI-Expanded, Scopus)

45. Clinical predictors of a frequently relapsing disease course under 5-ASA amongst ulcerative colitis patients initially responding to induction therapy with 5-ASA and/or steroids

Atay K., Erzin Y., Hatemi I., Eskazan T., Serin I., Bozcan S., et al.

JOURNAL OF CROHNS & COLITIS , vol.10, 2016 (SCI-Expanded, Scopus)

46. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in behcet's syndrome a strobe-compliant observational study from a dedicated multidisciplinary center

Hatemi I., Esatoglu S. N., Hatemi G., Erzin Y. Z., Yazici H., Celik A. F.

Medicine (United States) , vol.95, no.16, 2016 (SCI-Expanded, Scopus)

47. Double pylorus in a patient with Behçet's syndrome.

Hatemi I., Hatemi G., Erzin Y. Z., Aykut E., Çelik A. B.

Clinical and experimental rheumatology , vol.33, no.6 Suppl 94, 2015 (SCI-Expanded, Scopus)

48. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behcet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature

Hatemi I., Hatemi G., Pamuk O. N., Erzin Y., Çelik A. B.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.33, no.6, 2015 (SCI-Expanded, Scopus)

49. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature

Hatemi A. İ., Hatemi G., Pamuk Ö. N., Erzin Y. Z., Çelik A. F.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.94, no.6, pp.129-137, 2015 (SCI-Expanded, Scopus)

50. A reappraisal of the association between Behcet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review

Esatoglu S. N., Hatemi G., Çelik A. F., Hatemi I., Soysal T., Çelik A. B.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.33, no.6, 2015 (SCI-Expanded, Scopus)

51. Double pylorus in a patient with Behçet's syndrome.

Hatemi A. İ., Hatemi G., Erzin Y. Z., Çelik A. F.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.94, no.6, pp.138-140, 2015 (SCI-Expanded, Scopus)

52. What is our success on complex perianal fistulae healing under optimal medical treatment ending up with ileostomy?

Erzin Y., Ercaliskan A., Hatemi I., Baca B., Demir N., Bal K., et al.

JOURNAL OF CROHNS & COLITIS , vol.9, 2015 (SCI-Expanded, Scopus)

53. Hematologic Malignancies Among 1740 Inflammatory Bowel Disease Patients: Long term follow up Data from a Tertiary Center

Salihoglu A., Serin N., Esatoglu N., Yilmaz H., Sengul Y., Hatemi I., et al.

JOURNAL OF CROHNS & COLITIS , vol.9, 2015 (SCI-Expanded, Scopus)

54. Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy

Eskazan A. E., Hatemi I., Aydin S. O., Ar M. C., Soysal T.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, pp.233, 2014 (SCI-Expanded, Scopus, TRDizin)

55. Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C

Bugdaci M. S., KORKMAZ H., Demir A., BIYIK M., Temel T., GÖKTÜRK H. S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.5, pp.539-545, 2014 (SCI-Expanded, Scopus, TRDizin)

56. Familial chylomicronemia syndrome related chronic pancreatitis: a single-center study

Sisman G., Erzin Y., Hatemi I., Caglar E., Boga S., Singh V., et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL , vol.13, no.2, pp.209-214, 2014 (SCI-Expanded, Scopus)

57. Management of gastrointestinal Behcet's disease refractory to conventional treatment

Hatemi I., Hatemi G., Erzin Y., Celik A. F.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded, Scopus)

58. What is our success on complex perianal fistula healing in the clinic? From antibiotic to combined anti-TNF based treatment, ending with or without ileostomy

Erzin Y., Ercaliskan A., Hatemi I., Eyice D., Baca B., Demir N., et al.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded, Scopus)

59. The clinical comparative demographic features between inpatient and outpatient of IBD

Sadri S., Hatemi I., Erzin Y., Baca B., Celik A. F.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded, Scopus)

60. What is the real value of acid fast staining, PCR, and culture of endoscopically obtained tissue samples in diagnosis of gastrointestinal tuberculosis in patients with ileocecal inflammation? Comparative data from an Eastern European registry

Erzin Y., Hatemi I., Kuskucu M. A., Aygun G., Midilli K., Esatoglu S. N., et al.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded, Scopus)

61. Comparative retrospective assessment of prospectively recorded endoscopic and histological findings between CD and GI-TB; the first Eastern European registry data

Erzin Y., Esatoglu S. N., Hatemi I., Demir N., Dogusoy G., Erdamar S., et al.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded, Scopus)

62. Demographic features and long-term follow up outcome comparisons between patients with solo inflammatory bowel disease vs. inflammatory bowel disease and concomitant ankylosing spondylitis

Erzin Y., Eyvazov H., Hatemi I., Hatemi G., Celik A. F.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded, Scopus)

63. Bone marrow transplantation for Behçet's disease: A case report and systematic review of the literature

Soysal T., Salihoglu A., Esatoglu S. N., Gulturk E., Eskazan A. E., Hatemi G., et al.

Rheumatology (United Kingdom) , vol.53, no.6, pp.1136-1141, 2014 (SCI-Expanded, Scopus)

64. Concordance of Endoscopic Ultrasonography-Guided Fine Needle Aspiration Diagnosis with the Final Diagnosis in Subepithelial Lesions

Caglar E., HATEMİ A. İ., Atasoy D., Sisman G., ŞENTÜRK H.

CLINICAL ENDOSCOPY , vol.46, no.4, pp.379-383, 2013 (ESCI, Scopus)

65. CHARACTERISTICS, TREATMENT AND OUTCOME OF GI INVOLVEMENT IN BEHCET SYNDROME: EXPERIENCE IN A DEDICATED CENTER

Hatemi I., Hatemi G., Erzin Y., Celik A. F., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES , vol.71, pp.391, 2013 (SCI-Expanded, Scopus)

66. Massive Gastrointestinal Bleeding During the Course of Chronic Myelomonocytic Leukemia

SALIHOGLU A., HATEMI I., SENEL T. E., Aki H., FERHANOGLU B.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES , vol.22, no.1, pp.7, 2013 (SCI-Expanded, Scopus)

67. Endosonography-assisted transmural endoscopic drainage of pancreatic pseudocysts: A single center experience

Sisman G., Hatemi I., Erzin Y., Coskun M., Tuncer M., ŞENTÜRK H.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6, pp.741-746, 2012 (SCI-Expanded, Scopus, TRDizin)

68. NPRL2 gene expression in the progression of colon tumors

Yogurtcu B., Hatemi I., Aydın İ., Buyru N.

GENETICS AND MOLECULAR RESEARCH , vol.11, no.4, pp.4810-4816, 2012 (SCI-Expanded, Scopus)

69. Collagenous Colitis: A Retrospective Survey of Patients with Chronic Diarrhea

Hatemi A. İ., Senates E., Dobrucali A., Goksel S.

HEPATO-GASTROENTEROLOGY , vol.58, no.112, pp.1963-1967, 2011 (SCI-Expanded, Scopus) Sustainable Development

70. A rare case of primary systemic amyloidosis presenting with hepatic failure

Gullu B. E., Hatemi I., Ozbay G., Tuzuner N., Sonsuz A.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.22, no.1, pp.113-114, 2011 (SCI-Expanded, Scopus, TRDizin)

71. Adult Langerhans cell histiocytosis and sclerosing cholangitis: a case report and review of the literature

Hatemi I., Baysal B., Senturk H., Behzatoglu K., Bozkurt E. R., Ozbay G.

HEPATOLOGY INTERNATIONAL , vol.4, no.3, pp.653-658, 2010 (SCI-Expanded, Scopus)

72. A COMPARATIVE STUDY OF CLINICAL, ENDOSCOPIC AND HISTOLOGIC FINDINGS IN PATIENTS WITH GASTROINTESTINAL BEHCET'S DISEASE AND CROHN'S DISEASE

Celik A. F., Hatemi I., Hatemi G., Satir E., Erzin Y., Sisman G., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded, Scopus)

73. Mesalazine induced drug fever

Hatemi I., Goksu A., Dobrucali A. M.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES , vol.19, no.2, pp.222, 2010 (SCI-Expanded, Scopus)

74. The Efficacy of Interferon Treatment in HBeAg Positive Chronic Hepatitis B is Very Low in an Area With Exclusively D Genotype

Senturk H., Baysal B., Ozaras R., Zerdali H., Tabak F., Mert A., et al.

GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded, Scopus) Sustainable Development

75. Validation of Biochemical Markers for the Prediction of Liver Fibrosis and Activity in Hemodialysis Patients With Chronic Hepatitis C

Senturk H., Canbakan M., Canbakan B., HATEMİ A. İ., Toptas T., Tabak Ö. F., et al.

GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded, Scopus) Sustainable Development

76. Clinical utility of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces Cerevisiae antibodies for discriminating specific intestinal inflammations

Kocazeybek B., Aslan M., Erzin Y., Celik A., Hatemi I., Hatemi G., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.14, 2010 (SCI-Expanded, Scopus)

77. Anti-Saccharomyces cerevisiae (ASCA) antibody levels in a subgroup of patients with ulcerative colitis, Crohn's disease, GI Behcet, and GI tuberculosis: Correlations with disease duration, activity, and extension

Aslan M., Kocazeybek B., Celik A., Erzin Y., Hatemi I., Hatemi G., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.14, 2010 (SCI-Expanded, Scopus)

78. Frequency of pathergy phenomenon and other features of Behçet`s syndrome among patients with inflammatory bowel disease

Hatemi A. İ., Çelik A. F., Hatemi G., Melikoğlu M., Arzuhal N., Mat C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.50, no.4, pp.91-95, 2008 (SCI-Expanded, Scopus)

79. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk

Tahan V., Canbakan B., Balci H., DANE F., Akin H., Can G., et al.

HEPATO-GASTROENTEROLOGY , vol.55, no.85, pp.1433-1438, 2008 (SCI-Expanded, Scopus)

80. Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease

Hatemi I., Hatemi G., Çelik A. B., Melikoglu M., Arzuhal N., Mat C., et al.

Clinical and Experimental Rheumatology , vol.26, 2008 (SCI-Expanded, Scopus)

81. Leptin in nonalcoholic fatty liver disease.

Canbakan B., Tahan V., Balci H., Hatemi I., Erer B., Ozbay G., et al.

Annals of hepatology , vol.7, no.3, pp.249-54, 2008 (Scopus)

82. Correlation of clinical and histopathologic features of celiac disease

Dogusoy G. B., Esen T., Cetin S. E., Goksel S., Cullu F., Kutlu T., et al.

VIRCHOWS ARCHIV , vol.452, 2008 (SCI-Expanded, Scopus)

83. Low dose thalidomide in immunosupressive unresponsive IBD; Effectiviness and side effects

Hatemi I., Hatemi G., Senates E., Baysal B., Erzin Y., Celik A. F.

GASTROENTEROLOGY , vol.134, no.4, 2008 (SCI-Expanded, Scopus)

84. Menetrier's disease coexisting with ulcerative colitis and sclerosing cholangitis

Hatemi I., Çağlar E., Aksoy D., Goksel S., Dobrucali A. M.

DIGESTIVE AND LIVER DISEASE , vol.40, no.1, pp.78-79, 2008 (SCI-Expanded, Scopus)

85. Clinicopathologic features of tuberculous colitis diagnosed in endoscopic biopsies

Dogusoy G. B., Celik A. F., Cigerciogullari E., Goksel S., Cetin S. E., Baysal B., et al.

VIRCHOWS ARCHIV , vol.451, no.2, pp.225, 2007 (SCI-Expanded, Scopus)

86. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease

Canbakan B., Senturk H., TAHAN V., HATEMİ I., Balci H., Toptas T., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.70, no.3, pp.277-284, 2007 (SCI-Expanded, Scopus)

87. Comparison of virtual colonoscopy with conventional colonoscopy in detection of colorectal polyps.

Selcuk D., DEMIREL K., OZER H., BACA B., HATEMI I., Mihmanli I., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.17, no.4, pp.288-93, 2006 (Scopus, TRDizin) Sustainable Development

88. Dense eosinophilic infiltration of the mucosa preceding ulcerative colitis and mimicking eosinophilic colitis: report of two cases.

Uzunismail H., Hatemi I., Doğusoy G., Akin O.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.17, no.1, pp.53-7, 2006 (Scopus, TRDizin)

89. İnce bağırsak fizyolojisi ve motilite bozuklukları.

DOBRUCALI A. M., HATEMİ A. İ.

Türkiye Klinikleri Genel cerrahi.İnce bağırsak cerrahisi özel sayısı. 2005;1(8):3-12. , vol.1, no.8, pp.3-12, 2005 (Peer-Reviewed Journal)

90. Massive haemorrhage induced by low molecular weight heparin in a patient with steroid refractory ulcerative colitis

Kaya S., Hatemi I., Hamzaoglu I., Uzunismail H.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , vol.39, no.6, pp.613, 2004 (SCI-Expanded, Scopus)

91. Screening for iron overload in the Turkish population

Barut G., Balci H., Bozdayi M., Hatemi I., Ozcelik D., Senturk H.

DIGESTIVE DISEASES , vol.21, no.3, pp.279-285, 2003 (SCI-Expanded, Scopus)

92. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis

Yenerel M., HATEMİ A. İ., Keskin H.

HAEMATOLOGICA , vol.84, no.8, pp.766-767, 1999 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 26

1. The Evaluation of Cytogenetics Results Obtained from Behçet Disease with Gastrointestınal Involment

YILMAZ Ş., ESATOĞLU S. N., Kuru D., SALİHOĞLU A., ÇIRAKOĞLU A., HATEMİ G., et al.

13th National Congress of Medical Genetics with International Participation, Antalya, Turkey, 7 - 11 November 2018, pp.30, (Summary Text)

2. IMMUNOGENICITY OF INFLIXIMAB AMONG PATIENTS WITH BEHCET'S SYNDROME: A CONTROLLED STUDY

Esatoglu S. N., Akkoc F. N., Ozguler Y., Ozbakir F., Nohut O. K., Cevirgen D., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.767, (Summary Text)

3. FECAL CALPROTECTIN LEVELS AS AN INDICATOR OF ACTIVE DISEASE IN BEHCET'S SYNDROME PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A CONTROLLED STUDY

Esatoglu S. N., Hatemi I., Ozguler Y., Hatemi G., Uzun H., Çelik A. B., et al.

Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.331, (Summary Text)

4. FECAL CALPROTECTIN LEVEL LOOKS PROMISING IN IDENTIFYING ACTIVE DISEASE IN BEHCET'S SYNDROME PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A CONTROLLED AND PILOT STUDY

Esatoglu S. N., Hatemi I., Ozguler Y., Hatemi G., Uzun H., Celik A. F., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.93, (Summary Text)

5. Prevalence of Fecal Incontinence and Associated Risk Factors in Older Patients Outpatient Clinic

Yuruyen M., Demir N., Yavuzer H., Atay K., Demirdag F., Avci S., et al.

Annual Scientific Meeting of the American-Geriatrics-Society, California, United States Of America, 19 - 21 May 2016, vol.64, (Summary Text)

6. LES pressure is not decreased in overweight patients with gastroesophageal reflux disease

Murt A., Hatemi I.

NeuroGASTRO Conference, İstanbul, Turkey, 4 - 06 June 2015, vol.27, pp.87-88, (Summary Text)

7. HEMATOLOGIC MALIGNANCIES, MOSTLY MYELODYSPLASTIC SYNDROMES AMONG 1740 INFLAMMATORY BOWEL DISEASE PATIENTS: LONG TERM FOLLOW-UP DATA FROM A TERTIARY CENTER

Salihoglu A., Serin N., Esatoglu N., Yilmaz H., Sengul Y., Hatemi I., et al.

20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.489, (Summary Text)

8. Association Between Leptin Profile and Apoptosis in Patients With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease

Canbakan B., Senturk H., HATEMİ A. İ., Koroglu E., Tuncer M., Atay K., et al.

46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 May 2015, vol.148, (Summary Text)

9. Osteoporosis in Chronic Liver Disease

Hatemi I., Durcan E., Atay K., Caliskan T., CANBAKAN B., Tuncer M.

46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 May 2015, vol.148, (Summary Text)

10. DO LEPTIN PROFILE AND INSULIN RESISTANCE FAVOR OXIDATIVE STRESS AND DISEASE SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE?

Canbakan B., Senturk H., Hatemi I., Koroglu E., Tuncer M., Atay K., et al.

50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 22 - 26 April 2015, vol.62, (Summary Text)

11. GASTROINTESTINAL INVOLVEMENT AMONG PATIENTS WITH SYSTEMIC VASCULITIS

Esatoglu N., Hatemi G., Hanel I., Hatemi I., Erzin Y., Pale A. S., et al.

15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.996, (Summary Text)

12. Role of Oxidative Stress and Insulin Resistance in the Disease Severity of Non-Alcoholic Fatty Liver Disease

Canbakan B., Senturk H., Tuncer M., HATEMİ A. İ., Koroglu E., SONSUZ A., et al.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, United States Of America, 18 - 21 May 2013, vol.144, (Summary Text)

13. Characteristics, Treatment and Outcome of Gastrointestinal Involvement in Behcet's Syndrome: Experience in A Dedicated Center

Hatemi I., Hatemi G., Erzin Y., Celik A. F., Yazici H.

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 November 2012, vol.64, (Summary Text)

14. Insulin Resistance is Associated With Increased Apoptosis and Oxidative Stress in Non-Alcoholic Fatty Liver Disease

Canbakan B., Senturk H., Tuncer M., HATEMİ A. İ., Erzin Y., SONSUZ A., et al.

Digestive Disease Week (DDW), California, United States Of America, 19 - 22 May 2012, vol.142, (Summary Text)

15. The Diagnostic Sensitivity and Specificity of the Endosonography(EUS) and EUS-Guided Fine Needle Aspiration Biopsy of Upper Gastrointestinal Subepithelial Lesions

Caglar E., Canbakan B., Senturk R., HATEMİ A. İ., Senturk H.

Conference on Digestive Disease Week 2011, Illinois, United States Of America, 7 - 10 May 2011, vol.140, (Summary Text)

16. Hypertriglyceridemia Could Be an Etiological Factor in Chronic Pancreatitis

Sisman G., Senturk H., Hatemi A. İ., Senturk R., Ozdemir S.

Conference on Digestive Disease Week 2011, Illinois, United States Of America, 7 - 10 May 2011, vol.140, (Summary Text)

17. IS ALANINE AMINOTRANSFERASE A SURROGATE MARKER OF SEVERE HEPATOCYTE APOPTOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Senturk H., Canbakan B., Canbakan M., Hatemi I., Toptas T., Tabak O., et al.

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 14 - 18 April 2010, vol.52, (Summary Text)

18. Interobserver reproducibility of histopathologic features in celiac disease and correlation with clinical findings

Esen T., Dogusoy G. B., Cetin S. E., Goksel S., Cullu F., Kutlu H., et al.

27th International Congress of the International-Academy-of-Pathology, Athens, Greece, 12 - 17 October 2008, vol.53, pp.133-134, (Summary Text)

19. Frequency of Behcet's syndrome among patients with inflammatory bowel disease

Hatemi G., Hatemi I., Celik A., Melikoglu M., Arzuhal N., Mat C., et al.

Annual European Congress of Rheumatology (EULAR 2007), Barcelona, Spain, 13 - 16 June 2007, vol.66, pp.378, (Summary Text)

20. Azathioprine toxicity in the treatment of inflammatory bowel disease: Outpatient clinic experience of seven years

HATEMİ A. İ., Baysal B., Senates E., Erzin Y., Celik A.

Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

21. Bone mineral density in corticosteroid naive Crohn's disease patients

Baysal B., HATEMİ A. İ., Senates E., Erzin Y., Celik A.

Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

22. Hepatocyte apoptosis in NAFLD patients with elevated versus normal GGT

Canbakan B., Senturk H., OLGAÇ N. V., Balci H., Guler S. D., Sut N., et al.

Digestive Disease Week Meeting/107th Annual Meeting of the American-Gastroenterlogical-Association, Los-Angeles, Chile, 20 - 25 May 2006, vol.130, (Summary Text)

23. Biochemical, radiological and histological correlates in patients with non-alcoholic fatty liver disease with or without ALT elevation

Canbakan B., Ozgulle S., Hatemi I., Ozbay G., Dirican A., Velet M., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.191-192, (Summary Text)

24. A population survey for screening chronic liver diseases in 4261 individuals from Turkey

Hatemi I., Barut G., Balci H., Canbakan B., Yenice N., Senturk H.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.216-217, (Summary Text)

25. Biochemical, radiological, and histological correlates in patients with non-alcoholic fatty liver disease with elevated and normal liver enzymes

Canbakan B., Ozgulle S., HATEMİ A. İ., Velet M., Dirican A., SONSUZ A., et al.

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124, (Summary Text)

26. HFE mutation in Turkish population.

Barut G., Balci H., Bozdayi M., Hatemi I., Senturk H.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 1 - 05 November 2002, vol.36, (Summary Text)

Metrics

Publication

159

Publication (WoS)

143

Publication (Scopus)

122

Citation (WoS)

987

H-Index (WoS)

Citation (Scopus)

1257

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Thesis Advisory

Open Access